Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY, FIMM | Sorafenib |
CTRPv2 | sorafenib |
PharmacoGx | Sorafenib |
Database | Identifier |
---|---|
Smiles: | CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F |
Inchikey: | MLDQJTXFUGDVEO-UHFFFAOYSA-N |
Pubchem: | 216239 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SERPINI2 | CCLE | pan-cancer | AAC | 0.52 | 9e-33 |
mRNA | TIFAB | CCLE | pan-cancer | AAC | 0.45 | 2e-25 |
mRNA | PPP1R27 | CCLE | pan-cancer | AAC | 0.42 | 7e-22 |
mRNA | KCNE5 | CCLE | pan-cancer | AAC | 0.42 | 1e-21 |
mRNA | AZU1 | CCLE | pan-cancer | AAC | 0.41 | 9e-21 |
mRNA | MS4A6A | CCLE | pan-cancer | AAC | 0.42 | 4e-20 |
mRNA | SEL1L2 | CCLE | pan-cancer | AAC | 0.4 | 5e-20 |
mRNA | SLC26A8 | CCLE | pan-cancer | AAC | 0.4 | 5e-20 |
mRNA | RNASE2 | CCLE | pan-cancer | AAC | 0.4 | 3e-19 |
mRNA | CCL23 | CCLE | pan-cancer | AAC | 0.4 | 7e-19 |